Co-targeting CDK4/6 and AKT with endocrine therapy overcomes CDK4/6 inhibitor and endocrine therapy resistance in preclinical breast cancer models 09:15 - 09:40 Back to programme Speakers Henrik Ditzel Head of Research, University of Southern Denmark and Odense University Hospital